BEIJING - A drug producer in east China has been stripped of its license on charges of making counterfeit medicines, according to the country's drug safety watchdog.

Furentang Pharmaceutical, a company based in Nanchang, Jiangxi Province, was found producing several oral liquids and syrups of other companies without authorization under a forged consigned manufacturing document, said a statement issued by the State Food and Drug Administration (SFDA) on Sunday.

Furentang was fined 1,166,490 yuan ($185,000) while Li Wei, the company's legal representative, was barred from working in the industry for 10 years.

The statement also detailed a decision to revoke the license of a drug trader in northeast China, which was found providing certificates and transaction documents for individual drug sellers.

Chinese authorities have repeatedly pledged to root out illegal operations in the drug making and distribution sector, especially on counterfeiting drugs.

In a separate press release on Sunday, the SFDA and the Ministry of Public Security jointly issued a guideline calling for enhanced coordination between the two agencies in tackling drug-related offences.

The guideline highlighted prompt exchange on intelligence and quick reaction in performing duties.

In addition, drug authorities should provide free technical assistance to the police in such investigations, said the guideline.